Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
To not include the 1.2 million people with HIV in the United States is dangerous and irresponsible
Advocates claim victory after more than 1,000 people endorse a demand for inclusion.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The World Health Organization coordinates efforts to create flu and COVID-19 vaccines and to fight other global health issues.
The NIH-funded network has launched its first clinical trial in response to the new pandemic.
Monday, May 18 is HIV Vaccine Advocacy Day. Support science. Not sound bites.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
An $80,000 grant from The Campbell Foundation will help scientist Natalia Freund continue her HIV vaccine studies.
Intravenous administration allowed the marginally effective BCG vaccination to work better in monkeys.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
Promising news on the prevention front
The Phase IIb/III HVTN 702 trial will begin enrollment in southern Africa in the fall.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.